The Sift Here’s what we’re Sifting today

New drug study sparks hope

by Rachel Lynn Aldrich
Posted 4/30/20, 11:34 am

The experimental drug remdesivir could help speed the recovery of COVID-19 patients, the U.S. government announced on Wednesday. The biotech company Gilead and the U.S. National Institutes of Health conducted a major study on 1,063 hospitalized coronavirus patients around the world. Preliminary data indicated the drug shortened the recovery time by an average of four days and was associated with fewer deaths, said Dr. Anthony Fauci, the U.S. government’s top infectious disease expert. Officials are working to make remdesivir available to patients as quickly as possible.

Is this a light at the end of the tunnel? “What it has proven is that a drug can block this virus,” Fauci said. “This will be the standard of care.” The announcement fueled a surge in stocks around the world, with the Dow Jones Industrial Average gaining more than 530 points on Wednesday. Gilead developed remdesivir as a potential treatment for a variety of viruses. Most recently, it was tested as a treatment for Ebola, but it proved less effective than other options.

Dig deeper: Read Julie Borg’s report in Beginnings on why a vaccine is longer in coming.


Read more from The Sift Sign up for The Sift email
Rachel Lynn Aldrich

Rachel is an assistant editor for WORLD Digital. She is a Patrick Henry College and World Journalism Institute graduate. Rachel resides with her husband in Wheaton, Ill.

Read more from this writer

Comments

You must be a WORLD Member and logged in to the website to comment.
  • PAMom
    Posted: Thu, 04/30/2020 03:29 pm

    What is not being reported, including here, is that this drug is outrageously expensive per pill, when both the hydroxychloroquine and the Z-pac only cost pennies per pill. Dr. Fauci is not someone I would trust. Check out his past associations.

  • Allen Johnson
    Posted: Thu, 04/30/2020 05:06 pm

    Remsdesevir is not a pill, it is a series of injections. Likely expensive just because of multiple injections. But also expensive is several more days in a hospital.

    Hydroxchoroquine is not showing effectiveness, despite what President Trump has pushed.  So no silver bullet yet.

  • RC
    Posted: Thu, 04/30/2020 10:12 pm

    “…was associated with fewer deaths…” If is more expensive, so what, if it saves your life!

ADVERTISEMENT